about
Reference intervals: current status, recent developments and future considerationsTurkish population structure and genetic ancestry reveal relatedness among Eurasian populationsUse of total patient data for indirect estimation of reference intervals for 40 clinical chemical analytes in Turkey.Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey.Two distinct training methods for a doctrine of life with healthy heart in a low socioeconomic society model.Short term effects of a low-carbohydrate diet in overweight and obese subjects with low HDL-C levels.Algorithm for predicting CHD death risk in Turkish adults: conventional factors contribute only moderately in womenControlling hypertension in Turkey: not a hopeless dreamPrevalence of peripheral arterial disease and related risk factors in Turkish eldersDGAT1 promoter polymorphism associated with alterations in body mass index, high density lipoprotein levels and blood pressure in Turkish women.Prevalence of Cardiovascular Disease Risk Factors in Migrants Participating in the PEP Family Heart Study, NurembergDynamics in Cardiometabolic Risk among Turkish Adults: Similarities to that in Iranians?Decreasing trends in cardiovascular mortality in Turkey between 1988 and 2008.A population-based survey of Chronic REnal Disease In Turkey--the CREDIT study.Metabolic syndrome as an underlying disease entity and its relationship to subclinical atherosclerosis in Andean Hispanics.Depressive symptoms in a general population: associations with obesity, inflammation, and blood pressure.Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.Fatty liver disease: Disparate predictive ability for cardiometabolic risk and all-cause mortalityAnalysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study.An Overview on Coronary Heart Disease (A Comparative Evaluation of Turkey and Europe) and Cost-effectiveness of Diagnostic StrategiesRelatively high levels of serum adiponectin in obese women, a potential indicator of anti-inflammatory dysfunction: relation to sex hormone-binding globulinChanges in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012Erosive esophagitis associated with metabolic syndrome, impaired liver function, and dyslipidemiaImpaired fasting glucose: Pro-diabetic, "atheroprotective" and modified by metabolic syndrome.High adiponectin levels fail to protect against the risk of hypertension and, in women, against coronary disease: involvement in autoimmunity?Perceived barriers to physical activity in university students.Low acylation stimulating protein levels are associated with cardiometabolic disorders-secondary to autoimmune activation?Rheumatoid factor mediates excess serum lipoprotein(a) for independent association with type 2 diabetes in men.Obesity and cardiovascular disease risk among Turkish and Moroccan migrant groups in Europe: a systematic review.Fasting glycemia and glycated hemoglobin categories: Relationship to serum lipoprotein(a) level and disparity in 2 geographic regional groups of Turkey.Cardiovascular risk factor trends in the Eastern Mediterranean region: evidence from four countries is alarming.Blunted heart rate recovery is associated with exaggerated blood pressure response during exercise testing.Cardiovascular risk factor levels in a lower middle-class community in Ankara, Turkey.Distinction of hypertriglyceridemic waist phenotype from simple abdominal obesity: interaction with sex hormone-binding globulin levels to confer high coronary risk.Risk of obesity and metabolic syndrome associated with FTO gene variants discloses clinically relevant gender difference among Turks.Sex-Specific Predictors of Metabolic Syndrome Independent of Its Components.Serum creatinine is associated with coronary disease risk even in the absence of metabolic disorders.A novel allele in the promoter of the hepatic lipase is associated with increased concentration of HDL-C and decreased promoter activity.Abdominal obesity with hypertriglyceridaemia, lipoprotein(a) and apolipoprotein A-I determine marked cardiometabolic risk.Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks.
P2860
Q26765321-3FE5FFE2-F2BA-4C85-B604-970628C242A6Q28259714-7D19B488-1F14-4F8B-BF87-49B013C1BEF5Q31044324-32593424-1272-47CD-BC27-683038729735Q33239514-FDD060C7-9834-4068-8E9B-F6EE06EB8DEDQ33565775-A25DCDEB-A668-4EAC-84DD-78644FD16DD9Q33742837-730D769E-1C4F-45BC-B82D-DE61A5D9CA72Q33814237-E19B91ED-32A0-41E5-A790-0E4B109591B4Q33873260-33A8417B-BA1B-47FD-8E4E-E96B32415EFEQ34022298-AA8B82F0-6AD9-40D3-9DDE-2647A2AA2BF0Q34139451-F2F61B5A-7D8E-4B66-8A10-76DE75B69F69Q34786463-EC8710F4-46B7-49B4-B517-A40009A6B02DQ34978677-AFE63E46-43E1-499A-9C04-2CD9D29F6228Q35002144-A949F54E-AB95-4F67-B071-8F4DCCE04588Q35023531-C1B1E395-01FD-4EE4-8B57-1C97EE27C067Q35181651-A3B08E2E-74F5-4753-BC08-1503918F410AQ35636136-699C322C-C7D5-4526-96B7-2EACA1DA1D9DQ35737842-C3B09B20-3C2E-4496-BB44-15BBD33EE64CQ36401621-AFE226DC-CF8D-4DE1-8225-E4F652DD5677Q36473611-AA961F82-E797-4EA8-943B-C8E185E7C74DQ36664605-56E95A6F-BBAC-41D6-AB3A-C77D179292D0Q36801068-23CB914D-7875-4F0A-8620-9881D33E67A0Q36868139-BACF1B21-8A93-4890-8AC0-1929C73638FFQ37221536-30C34EA3-59A2-43F1-8BFC-014131C94448Q37232688-E421CEA5-C94F-4DF6-8BBB-39A0BFF7568FQ37232691-F504F400-4C27-4FF4-A079-C42579F3415FQ37389067-3D7CE2DA-4CDE-4D3D-BF21-7FB664B4CD1DQ37680316-6DE61C8D-6986-4A98-AB91-8A3E17FC3E76Q37680564-DB538AE4-D628-4692-830C-E8D025BC62A9Q37939365-91913FC6-DB8E-4BE3-84C3-D8D2D4919EEFQ39184189-FDAA28D4-8B44-461B-816C-7F11E3131818Q39503847-D111286D-9A4F-4121-B579-99F2D4746A1BQ39534068-F33C5128-4B6B-4F00-87AC-86DD63B83546Q39653213-F0450799-AD50-423A-82E3-50CCB0908884Q40474673-1E559283-A1C6-42FB-99A7-522D6DB2B1E0Q40768597-E74519E1-E197-4FDB-89B6-79907744C9DCQ41741676-A8DD2162-2FD0-41BF-A291-DD1F6621E02BQ43965678-488E596F-8EEB-4E8D-97AE-390CCAE268E5Q44168278-34BC6E22-9340-44D6-8E80-58C3CF64CFDBQ44290948-19DA7A4A-B39E-4635-AF13-AE6F8F3D2193Q46147591-E28DA387-3B92-41B6-8FAC-A8478BE0A902
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Risk factors and cardiovascular disease in Turkey.
@ast
Risk factors and cardiovascular disease in Turkey.
@en
Risk factors and cardiovascular disease in Turkey.
@nl
type
label
Risk factors and cardiovascular disease in Turkey.
@ast
Risk factors and cardiovascular disease in Turkey.
@en
Risk factors and cardiovascular disease in Turkey.
@nl
prefLabel
Risk factors and cardiovascular disease in Turkey.
@ast
Risk factors and cardiovascular disease in Turkey.
@en
Risk factors and cardiovascular disease in Turkey.
@nl
P1433
P1476
Risk factors and cardiovascular disease in Turkey.
@en
P2093
P356
10.1016/S0021-9150(01)00500-7
P577
2001-05-01T00:00:00Z